Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Non-infectious endocarditis and myocarditis after COVID-19 mRNA vaccination.
Aikawa T, Ogino J, Kita Y, Funayama N, Oyama-Manabe N. Aikawa T, et al. Among authors: funayama n. Eur Heart J Case Rep. 2022 Jan 3;6(1):ytab533. doi: 10.1093/ehjcr/ytab533. eCollection 2022 Jan. Eur Heart J Case Rep. 2022. PMID: 35047749 Free PMC article. No abstract available.
Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.
Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group. Umemoto S, et al. Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1. Hypertens Res. 2017. PMID: 27904156 Free PMC article. Clinical Trial.
Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.
Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group. Matsuzaki M, et al. J Hypertens. 2011 Aug;29(8):1649-59. doi: 10.1097/HJH.0b013e328348345d. J Hypertens. 2011. PMID: 21610513 Clinical Trial.
Myocardial microthrombi after COVID-19 mRNA vaccination.
Aikawa T, Ogino J, Kita Y, Funayama N. Aikawa T, et al. Among authors: funayama n. Eur Heart J. 2021 Nov 14;42(43):4501. doi: 10.1093/eurheartj/ehab727. Eur Heart J. 2021. PMID: 34624077 Free PMC article. No abstract available.
Vasospastic Angina: A Cause of Post-acute COVID-19 Syndrome.
Aikawa T, Ogino J, Oyama-Manabe N, Funayama N. Aikawa T, et al. Among authors: funayama n. Intern Med. 2022 Sep 1;61(17):2693-2695. doi: 10.2169/internalmedicine.0137-22. Epub 2022 Jun 28. Intern Med. 2022. PMID: 35768219 Free PMC article. No abstract available.
Myocardial microthrombi after COVID-19 mRNA vaccination.
Aikawa T, Ogino J, Kita Y, Funayama N. Aikawa T, et al. Among authors: funayama n. Eur Heart J. 2021 Nov 14;42(43):4501. doi: 10.1093/eurheartj/ehab727. Eur Heart J. 2021. PMID: 36282722 No abstract available.
105 results